Heart rehab and its effect on DNA and inflammation
Part of Heart & circulation clinical trials.
This study looks at whether a cardiac rehabilitation program can reduce DNA damage and inflammation in people with coronary artery disease. It may help patients understand how exercise and lifestyle changes can affect their heart health at a cellular level.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You have been diagnosed with coronary artery disease.
- You can safely take part in exercise testing and a rehab program.
- You are able to understand and follow study instructions.
- You do not have heart failure, unstable angina, or a pacemaker.
- You do not have any condition that prevents exercise, like joint or nerve problems.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a home-based cardiac rehabilitation program delivered through a smartphone app for people with coronary heart disease. If you join, you'll use the app to track your health and get support, which may help you recover and stay heart-healthy.
This study looks at whether a heart rehab program can affect a type of cell damage (ferroptosis) in people who recently had heart artery disease. It could help show why rehab is good for recovery.
This study tests if a cardiac rehabilitation program helps people with coronary artery disease. You can join if you are between 40 and 70, have heart disease (or are a healthy volunteer), and do not have other health issues like heart failure or smoking.
This study follows people with coronary artery disease who are starting a structured heart rehabilitation program after a heart attack or heart procedures. The trial tests whether it can predict and improve the right timing or planning for cardiac rehab.
This study tests a cardiac rehabilitation program designed for people with a high genetic risk of arrhythmogenic cardiomyopathy (a condition that affects the heart's rhythm and structure). It aims to see if a safe, supervised exercise plan can help improve heart function and quality of life.
This study tracks how well heart rehabilitation works for people with coronary artery disease or heart failure. It aims to improve future care by learning from your experience.
Hear when a new Coronary Arterial Disease (CAD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.